Amniotic Fluid Analysis

Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · Nov 9, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the analysis of amniotic fluid to help understand complications that can occur during labor. The goal is to see if the research team can quickly and accurately collect this fluid to gather important information that will help in future studies. This research will be particularly useful for better planning and conducting similar studies down the line.

To be eligible for this trial, participants need to be women who are at least 18 years old and are pregnant with a single baby (not twins or more) at 37 weeks of pregnancy or later. Unfortunately, women with certain conditions, like multiple pregnancies, specific health issues, or infections, won’t be able to participate. If you join the trial, you can expect close support from the clinical team during labor, and the process will be carefully monitored to ensure everything runs smoothly. This study is currently not recruiting participants, but it is an important step toward improving care for women during labor.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Singleton pregnancy
• • Gestational age ≥ 37 weeks
• • Age of participant ≥ 18 years old
• Exclusion Criteria:
• • Multiple gestation
• • Gestational age \< 37 weeks
• • Intrauterine fetal demise
• • Fetal anomalies
• • Pre-gestational Diabetics / Gestational Diabetics
• • Chronic immune suppression with steroids (defined as \> 1 month of consistent steroid use)
• • Oligohydramnios
• • Women with documented non-obstetric infections within 2 weeks of admission; including use of any antibiotics within 2 weeks of admission for non-documented/suspected infections
• • Repeat temperature not performed within 45 minutes of index fever (100.4 F)
• • Index fever (100.4 F) is \> 1 hour after delivery
• • Expectantly managed premature rupture of membranes